Bibliographical noteFunding Information:
Dr Inga Bayh of Bayer AG, Wuppertal, Germany, was responsible for the statistical analysis of this study. This study was supported by Bayer. Medical writing assistance was provided by Fishawack Communications Ltd., which was fully funded by Bayer.
Copyright 2020 Elsevier B.V., All rights reserved.
- BAY 94-9027
- PROTECT VIII trial
- damoctocog alfa pegol
- haemophilia A
- target joint
PubMed: MeSH publication types